Targeting All BRAF Alterations: The (Re)-Search Continues.

Deepak Bhamidipati Andrew J Pellatt Vivek Subbiah

Published in: JCO precision oncology (2024)

VivekSubbiah & colleagues delve into the @ASCO #TAPURStudy, shedding light on the importance of targeting ALL #BRAFAlterations, beyond V600E. (Re)-search continues, urging us to push the boundaries and unlock new possibilities in #PrecisionMedicine. #CancerResearch #JCOPO.

Keyphrases

cancer therapy
drug delivery
wild type